Articles
| Open Access |
https://doi.org/10.55640/
ACROMEGALY: A CONTEMPORARY REVIEW OF PATHOPHYSIOLOGY, DIAGNOSIS, AND TREATMENT APPROACHES
Ergasheva Gulshan Toxirovna , Asia International UniversityAbstract
Acromegaly is a chronic neuroendocrine disorder caused by excessive secretion of growth hormone (GH) and elevated insulin-like growth factor-1 (IGF-1), typically resulting from a GH-producing pituitary adenoma. The disease develops insidiously and is often diagnosed late, after irreversible systemic complications have developed. This article provides an expanded, evidence-based overview of the etiology, pathogenesis, epidemiology, clinical manifestations, diagnostic algorithms, and modern management strategies for acromegaly. Acromegaly is a rare disease, caused largely by a growth hormone (GH) pituitary adenoma. Incidence is higher than previously thought. Due to increased morbidity and mortality, if not appropriately treated, early diagnosis efforts are essential. Screening is recommended for all patients with clinical features of GH excess. There is increased knowledge that classical diagnostic criteria no longer apply to all, and some patients can have GH excess with normal GH response to glucose. Treatment is multifactorial and personalised therapy is advised.
Keywords
Acromegaly, growth hormone, pituitary adenoma, somatostatin receptor ligand
References
1. Ergasheva, G. (2025). POLYCYSTIC OVARY SYNDROME: A COMPREHENSIVE OVERVIEW AND CURRENT TREATMENT APPROACHES. Modern Science and Research, 4(4), 937-944.
Ergasheva, G. (2025). ACROMEGALY: A SEVERE NEUROENDOCRINE DISORDER WITH MULTISYSTEM MANIFESTATIONS. Modern Science and Research, 4(3), 1123-1131.
Ergasheva, G. (2024). THE ROLE OF CORRECTIONAL PEDAGOGY IN ORGANIZING THE EDUCATION OF CHILDREN WITH DISABILITIES. Ethiopian International Journal of Multidisciplinary Research, 11(06), 206-207.
Toxirovna, E. G. (2024). QALQONSIMON BEZ KASALLIKLARIDAN HASHIMOTO TIREODIT KASALLIGINING MORFOFUNKSIONAL O’ZIGA XOSLIGI. Modern education and development, 16(7), 120-135.
Toxirovna, E. G. (2024). REVMATOID ARTRIT: BO’G'IMLAR YALLIG'LANISHINING SABABLARI, KLINIK BELGILARI, OQIBATLARI VA ZAMONAVIY DAVOLASH YONDASHUVLARI. Modern education and development, 16(7), 136-148.
Эргашева, Г. Т. (2024). ОЦЕНКА КЛИНИЧЕСКОЙ ЭФФЕКТИВНОСТИ ОРЛИСТАТА У БОЛЬНЫХ ОЖИРЕНИЕМ И АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ. Modern education and development, 16(7), 92-105.
Ergasheva, G. T. (2024). THE SPECIFICITY OFAUTOIMMUNE THYROIDITIS IN PREGNANCY. European Journal of Modern Medicine and Practice, 4(11), 448-453.
Эргашева, Г. Т. (2024). ИССЛЕДОВАНИЕ ФУНКЦИИ ЩИТОВИДНОЙ ЖЕЛЕЗЫ ПРИ ТИРЕОИДИТЕ ХАШИМОТО. Modern education and development, 16(7), 106-119.
Toxirovna, E. G. (2024). GIPOFIZ ADENOMASINI NAZORAT QILISHDA KONSERVATIV JARROHLIK VA RADIATSIYA TERAPIYASINING UZOQ MUDDATLI SAMARADORLIGI. Modern education and development, 16(7), 79-91.
ERGASHEVA, G. T. (2024). OBESITY AND OVARIAN INSUFFICIENCY. Valeology: International Journal of Medical Anthropology and Bioethics, 2(09), 106-111.
Ergasheva, G. T. (2024). Modern Methods in the Diagnosis of Autoimmune Thyroiditis. American Journal of Bioscience and Clinical Integrity, 1(10), 43-50.
Tokhirovna, E. G. (2024). COEXISTENCE OF CARDIOVASCULAR DISEASES IN PATIENTS WITH TYPE 2 DIABETES. TADQIQOTLAR. UZ, 40(3), 55-62.
Toxirovna, E. G. (2024). DETERMINATION AND STUDY OF GLYCEMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH COMORBID DISEASES. TADQIQOTLAR. UZ, 40(3), 71-77.
Toxirovna, E. G. (2024). XOMILADORLIKDA QANDLI DIABET KELTIRIB CHIQARUVCHI XAVF OMILLARINI ERTA ANIQLASH USULLARI. TADQIQOTLAR. UZ, 40(3), 63-70.
Toxirovna, E. G. (2024). QANDLI DIABET 2-TIP VA KOMORBID KASALLIKLARI BO’LGAN BEMORLARDA GLIKEMIK NAZORAT. TADQIQOTLAR. UZ, 40(3), 48-54.
Tokhirovna, E. G. (2024). MECHANISM OF ACTION OF METFORMIN (BIGUANIDE) IN TYPE 2 DIABETES. JOURNAL OF HEALTHCARE AND LIFE-SCIENCE RESEARCH, 3(5), 210-216.
Tokhirovna, E. G. (2024). THE ROLE OF METFORMIN (GLIFORMIN) IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 4(4), 171-177.
Эргашева, Г. Т. (2024). Эффект Применения Бигуанида При Сахарным Диабетом 2 Типа И Covid-19. Research Journal of Trauma and Disability Studies, 3(3), 55-61.
Toxirovna, E. G. (2024). QANDLI DIABET 2 TUR VA YURAK QON TOMIR KASALLIKLARINING BEMOLARDA BIRGALIKDA KECHISHI. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 38(7), 202-209.
Эргашева, Г. Т. (2024). СОСУЩЕСТВОВАНИЕ ДИАБЕТА 2 ТИПА И СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ У ПАЦИЕНТОВ. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 38(7), 219-226.
Article Statistics
Downloads
Copyright License

This work is licensed under a Creative Commons Attribution 4.0 International License.